Urticarial vasculitis ranges from a mild, skin-limited nuisance to a serious systemic disease, depending on one key factor: whether your complement levels (a set of immune proteins measured through blood tests) are normal or low. The normocomplementemic form, where complement levels stay normal, is typically benign and confined to the skin. The hypocomplementemic form can affect the lungs, kidneys, joints, and eyes, with 5-year and 10-year survival rates of 92% and 83%, respectively.
Understanding which type you have, and what warning signs to watch for, determines how worried you should need to be.
How It Differs From Regular Hives
Urticarial vasculitis looks like hives at first glance, which is why it often takes a while to get diagnosed correctly. But there are reliable differences. In a large international study comparing urticarial vasculitis to chronic spontaneous hives, several features stood out. Wheals (the raised, red patches) that last 24 hours or longer were 7.3 times more likely to signal urticarial vasculitis. Skin pain, rather than just itching, was 7 times more common. And brownish or purplish discoloration left behind after wheals faded was 4.1 times more likely.
Ordinary hives itch, shift around the body, and disappear within a few hours without a trace. Urticarial vasculitis lesions burn or sting, stay fixed in one spot for a day or more, and often leave behind bruise-like marks. People with urticarial vasculitis are also significantly more likely to experience fatigue, fever, and eye inflammation compared to those with regular chronic hives.
The Two Types and Why It Matters
The distinction between normocomplementemic and hypocomplementemic urticarial vasculitis is the single most important factor in determining severity.
Normocomplementemic urticarial vasculitis (normal complement levels) is the milder form. It primarily affects the skin with little risk of organ involvement. Only about 2% of people with this type also have lupus. For most, the condition is uncomfortable but not dangerous, and treatment focuses on controlling skin symptoms.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a different story. Low complement levels signal a more aggressive immune process that can attack organs throughout the body. Over half of people with this form (54%) also meet diagnostic criteria for systemic lupus erythematosus or eventually develop it. HUVS can involve angioedema (deep tissue swelling), arthritis, gastrointestinal symptoms, eye inflammation, and damage to the lungs and kidneys.
Lung Involvement Is the Biggest Concern
Pulmonary complications are the leading cause of death in urticarial vasculitis. Lung involvement affects an estimated 20 to 50% of people with HUVS, and the damage can be severe. The immune system produces an autoantibody that binds to proteins in the lungs, triggering inflammation and the release of enzymes that destroy lung tissue. This leads to emphysema and obstructive lung disease that resembles COPD, even in people who have never smoked.
In some cases, the lung damage is extensive before symptoms become obvious. One documented case involved a 40-year-old man whose lung function had dropped to just 30% of predicted capacity by the time he was evaluated, despite having no prior lung disease. His lung biopsies revealed vasculitis in the small blood vessels and a severe pattern of emphysema caused entirely by the autoimmune process. Studies have found that 80 to 100% of HUVS patients with the characteristic autoantibody develop some degree of obstructive lung disease. Smoking compounds the risk significantly and is associated with a worse short-term prognosis.
Kidney Damage in HUVS
Up to 50% of people with HUVS develop some degree of kidney involvement. The most common signs are blood in the urine combined with protein in the urine, which together appeared in 70% of HUVS patients with kidney problems in a case-based review. About one-third of those with kidney involvement already had significantly reduced kidney function at the time it was first detected.
The kidney damage typically takes the form of inflammation in the filtering units, with several patterns possible. The good news is that even patients with extensive kidney involvement tend to maintain a fairly good overall prognosis when monitored and treated. The key is catching it early through routine urine and blood tests, since kidney damage rarely causes noticeable symptoms until it’s advanced.
How It’s Diagnosed
A skin biopsy is the definitive test. Under a microscope, urticarial vasculitis shows a specific pattern of inflammation in the small blood vessels of the skin. Immune cells called neutrophils infiltrate the vessel walls and break apart, leaving behind fragments sometimes described as “nuclear dust.” The vessel walls themselves show damage, with a characteristic deposit of fibrin (a clotting protein) and red blood cells leaking into the surrounding tissue. The presence of certain immune cells called eosinophils in the biopsy can suggest the vasculitis is drug-related or specifically urticarial in nature.
Beyond the biopsy, blood tests measuring complement levels (C3, C4, and sometimes C1q antibodies) determine which type you have and how closely you need to be monitored. If lung symptoms like shortness of breath are present, chest imaging and breathing tests are recommended because of the strong link between HUVS and lung disease.
Treatment and What to Expect
Treatment depends entirely on severity. For normocomplementemic urticarial vasculitis limited to the skin, antihistamines are usually the starting point. When antihistamines aren’t enough, anti-inflammatory medications that tamp down the immune response may be added. One biologic medication originally approved for chronic hives has shown strong results, with roughly 90% of chronic hive patients in one review responding positively within three months. It can also reduce the need for oral steroids.
HUVS with organ involvement requires more aggressive treatment aimed at suppressing the underlying autoimmune activity. The specific approach depends on which organs are affected and how severely. Treatment for HUVS is typically long-term, and the goal shifts from eliminating symptoms to preventing progressive organ damage, particularly in the lungs and kidneys.
Signs That Need Prompt Attention
If you’ve been diagnosed with urticarial vasculitis or suspect you have it, certain symptoms suggest the disease is moving beyond the skin. Progressive shortness of breath or reduced exercise tolerance can signal lung involvement. Foamy urine, blood-tinged urine, or unexplained swelling in the legs or around the eyes may indicate kidney problems. Joint pain and swelling, persistent fatigue, fevers, abdominal pain, or eye redness and pain all point to systemic disease that needs evaluation.
The trajectory of urticarial vasculitis varies widely. Some people have a single episode that resolves. Others deal with a chronic but manageable skin condition for years. A smaller subset faces serious organ complications that require ongoing care. The distinction almost always comes down to complement levels and the presence of autoantibodies, which is why getting the right blood work early on shapes everything that follows.